We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
Cap. Flow
+$754M
Cap. Flow %
4.96%
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$124M
2
TXN icon
Texas Instruments
TXN
+$113M
3
UNH icon
UnitedHealth
UNH
+$106M
4
PM icon
Philip Morris
PM
+$106M
5
TJX icon
TJX Companies
TJX
+$93.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Consumer Discretionary 12.3%
3 Technology 11.57%
4 Communication Services 10.98%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUVA
626
DELISTED
NuVasive, Inc.
NUVA
$2.09M 0.01%
31,008
-30,108
-49% -$1.94M
NSTG
627
DELISTED
NanoString Technologies, Inc.
NSTG
$2.07M 0.01%
+93,001
New +$1.99M
ESL
628
DELISTED
Esterline Technologies
ESL
$2.07M 0.01%
23,174
+11,600
+100% +$949K
NILE
629
DELISTED
Blue Nile, Inc.
NILE
$2.05M 0.01%
+50,532
New +$1.93M
AGEN
630
Agenus
AGEN
$249M
$2.04M 0.01%
+25,276
New +$2.48M
SKX
631
DELISTED
Skechers
SKX
$2.04M 0.01%
+83,003
New +$1.91M
AEO icon
632
American Eagle Outfitters
AEO
$2.85B
$2.04M 0.01%
+134,223
New +$2.3M
BBG
633
DELISTED
Bill Barrett Corp
BBG
$2.03M 0.01%
+290,432
New +$1.86M
GPRE icon
634
Green Plains
GPRE
$1.19B
$2.03M 0.01%
72,807
-28,606
-28% -$761K
SGRY icon
635
Surgery Partners
SGRY
$2.06B
$2.01M 0.01%
126,995
-33,732
-21% -$561K
HRG
636
DELISTED
HRG Group, Inc.
HRG
$2.01M 0.01%
129,033
-98,832
-43% -$1.51M
GPACU
637
DELISTED
Global Partner Acquisition Corp. Units
GPACU
$2M 0.01%
+200,000
New +$2M
MGLN
638
DELISTED
Magellan Health Services, Inc.
MGLN
$2M 0.01%
+26,554
New +$1.7M
RRD
639
DELISTED
RR Donnelley & Sons Co.
RRD
$2M 0.01%
+122,354
New +$2.2M
MELI icon
640
Mercado Libre
MELI
$91.3B
$1.95M 0.01%
12,475
+1,019
+9% +$168K
HQY icon
641
HealthEquity
HQY
$7.91B
$1.95M 0.01%
+48,044
New +$1.86M
RMP
642
DELISTED
Rice Midstream Partners LP
RMP
$1.94M 0.01%
79,088
-36,415
-32% -$811K
PCG icon
643
PG&E
PCG
$47.8B
$1.94M 0.01%
31,920
+27,572
+634% +$1.65M
ARGO
644
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$1.94M 0.01%
+33,797
New +$1.8M
ALLY icon
645
Ally Financial
ALLY
$13.1B
$1.91M 0.01%
+100,364
New +$1.93M
BECN
646
DELISTED
Beacon Roofing Supply, Inc.
BECN
$1.89M 0.01%
41,029
-497,748
-92% -$22.2M
FMC icon
647
FMC
FMC
$1.42B
$1.88M 0.01%
38,338
-6,691
-15% -$306K
SSL icon
648
Sasol
SSL
$7.58B
$1.88M 0.01%
+65,642
New +$1.8M
BWLD
649
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$1.88M 0.01%
12,157
-26,756
-69% -$4.16M
ELGX
650
DELISTED
Endologix Inc
ELGX
$1.87M 0.01%
32,730
+26,172
+399% +$2.4M

Similar funds

Marshall Wace's Q4 2016 Portfolio in Review

As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.

  • Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
  • Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
  • Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
  • Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
  • Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
  • Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.